Explore advancements in lung cancer detection and prevention, including early screening and innovative vaccine developments for better outcomes.

New Curtin University research has found Australians exposed to asbestos could be falling through the cracks of lung cancer screening programs. The study, published in Occupational and Environmental Medicine,

Lung cancer remains one of the world's deadliest cancers, yet despite decades of effort to develop new drugs, many fail because they don't stay in the body long enough to be effective or because they damage healthy organs.

At ASCO 2026, companies debuted data that could hold the potential to disrupt the frontline treatment paradigm for various subtypes of NSCLC.

Lung cancer is the leading cause of cancer deaths, causing approximately 1.8 million deaths worldwide.1 Screening with low-dose CT (LDCT) has been shown to significantly reduce lung cancer-specific mortality among populations at high-risk by 20–26%.

A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers, including lung cancer.

Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa demonstrated superior survival rates in early-stage ALK-positive ...

Lung cancer is the most common and deadly form of cancer worldwide. It is increasingly understood to be a complex genetic disease with different mutations that vary according to factors such as smoking and ethnicity.

In August, UVA Cancer Center became the first in Virginia to offer lung cancer patients the new drug tarlatamab, approved in May as immunotherapy to supercharge the body’s immune system to fight small-cell lung cancer in combination with chemotherapy.